StockWatch
·
Biotechnology: Pharmaceutical Preparations
BuybackOct 13, 2026, 04:41 PM

Lakefront Biotherapeutics Buys Back 126,322 Shares for €3.3M

AI Summary

Lakefront Biotherapeutics NV announced that between October 5 and October 9, 2026, it repurchased 126,322 of its own shares. These repurchases were conducted through a discretionary mandate to an independent financial intermediary as part of a previously announced repurchase program. The total amount spent on these repurchases was €3,317,407.94, with an average price of €26.26 per share. Following these transactions, Lakefront holds 1,877,353 of its own ordinary shares.

Key Highlights

  • Lakefront Biotherapeutics repurchased 126,322 shares between October 5-9, 2026.
  • The average price paid for repurchased shares was €26.26.
  • Total amount spent on share repurchases was €3,317,407.94.
  • The lowest price paid for a share was €25.78 and the highest was €26.78.
  • As of October 9, 2026, Lakefront holds 1,877,353 of its own ordinary shares.